EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail
BRUSSELS — The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying cancer-screening company Grail without regulators' approval, the latest setback for the deal. Illumina announced an $7.1 billion acquisition of Grail in…